Search for: "Isom v. Isom" Results 1 - 20 of 136
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Sep 2007, 11:49 am
  This combination provided sufficient "reasoning with some rational underpinning to support" a conclusion of obviousness post-KSR.More detail of Aventis Pharma Deutschland GmbH v. [read post]
8 Nov 2010, 7:35 am by Karen E. Keller
In a case involving certain chemical analogs and optical isomers, Chief Judge Sleet construed the following terms: - "S-(+)-4-amino-3-(2-methylpropyl) butanoic acid as a single optical isomer" - "4-amino-3-(2-methylpropyl) butanoic acid" Pfizer, Inc. v. [read post]
29 Dec 2015, 8:00 pm by John Ehrett
The petition of the day is: Isom v. [read post]
18 May 2009, 7:00 am
  There was no clear and convincing evidence of overlap between the patents, so there was no double patenting.More detail of Procter & Gamble Co. v. [read post]
20 Jan 2012, 6:57 am by PaulKostro
Law Lessons from Lilly Buie and Antwan Moses v. [read post]
11 Oct 2012, 3:48 pm by John W. Arden
Instead, Merck’s allegations focused almost entirely on losses suffered by Merck itself, not the eventual—and theoretical— harm suffered by the public at large.The opinion in Merck Eprova AG v. [read post]